{"id":1394,"date":"2021-11-08T13:32:58","date_gmt":"2021-11-08T12:32:58","guid":{"rendered":"https:\/\/dextechmedical.com\/wp-content\/uploads\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo\u0308resla\u030ar-en-fo\u0308retra\u0308desemission-.pdf"},"modified":"2021-11-08T13:54:05","modified_gmt":"2021-11-08T12:54:05","slug":"211108-pm-dextech-styrelsen-i-dext-ech-fo%cc%88resla%cc%8ar-en-fo%cc%88retra%cc%88desemission-2","status":"inherit","type":"attachment","link":"https:\/\/dextechmedical.com\/en\/the-board-of-directors-of-dextech-proposes-a-rights-issue-of-approx-msek-58-2-in-order-to-further-develop-the-project-with-multiple-myeloma-to-clinical-research-and-further-verify-osteodexs-value\/211108-pm-dextech-styrelsen-i-dext-ech-fo%cc%88resla%cc%8ar-en-fo%cc%88retra%cc%88desemission-2\/","title":{"rendered":"211108 &#8211; PM &#8211; Dextech -Styrelsen i DexT ech fo\u0308resla\u030ar en fo\u0308retra\u0308desemission"},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-1394","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>211108 - PM - Dextech -Styrelsen i DexT ech fo\u0308resla\u030ar en fo\u0308retra\u0308desemission | DexTech<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dextechmedical.com\/wp-content\/uploads\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo?_resla?_r-en-fo?_retra?_desemission-.pdf\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"211108 - PM - Dextech -Styrelsen i DexT ech fo\u0308resla\u030ar en fo\u0308retra\u0308desemission | DexTech\" \/>\n<meta property=\"og:url\" content=\"\" \/>\n<meta property=\"og:site_name\" content=\"DexTech\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-08T12:54:05+00:00\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dextechmedical.com\\\/wp-content\\\/uploads\\\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo?_resla?_r-en-fo?_retra?_desemission-.pdf\",\"url\":\"https:\\\/\\\/dextechmedical.com\\\/wp-content\\\/uploads\\\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo?_resla?_r-en-fo?_retra?_desemission-.pdf\",\"name\":\"211108 - PM - Dextech -Styrelsen i DexT ech fo\u0308resla\u030ar en fo\u0308retra\u0308desemission | DexTech\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dextechmedical.com\\\/#website\"},\"datePublished\":\"2021-11-08T12:32:58+00:00\",\"dateModified\":\"2021-11-08T12:54:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dextechmedical.com\\\/wp-content\\\/uploads\\\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo?_resla?_r-en-fo?_retra?_desemission-.pdf#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dextechmedical.com\\\/wp-content\\\/uploads\\\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo?_resla?_r-en-fo?_retra?_desemission-.pdf\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dextechmedical.com\\\/wp-content\\\/uploads\\\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo?_resla?_r-en-fo?_retra?_desemission-.pdf#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dextechmedical.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Board of Directors of DexTech proposes a rights issue of approx. MSEK 58.2 in order to further develop the project with multiple myeloma to clinical research and further verify OsteoDex&#8217;s value\",\"item\":\"https:\\\/\\\/dextechmedical.com\\\/en\\\/the-board-of-directors-of-dextech-proposes-a-rights-issue-of-approx-msek-58-2-in-order-to-further-develop-the-project-with-multiple-myeloma-to-clinical-research-and-further-verify-osteodexs-value\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"211108 &#8211; PM &#8211; Dextech -Styrelsen i DexT ech fo\u0308resla\u030ar en fo\u0308retra\u0308desemission\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dextechmedical.com\\\/#website\",\"url\":\"https:\\\/\\\/dextechmedical.com\\\/\",\"name\":\"DexTech\",\"description\":\"Ett svenskt forskningsf\u00f6retag specialiserat p\u00e5 urologisk onkologi fr\u00e4mst prostatacancer\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dextechmedical.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"211108 - PM - Dextech -Styrelsen i DexT ech fo\u0308resla\u030ar en fo\u0308retra\u0308desemission | DexTech","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dextechmedical.com\/wp-content\/uploads\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo?_resla?_r-en-fo?_retra?_desemission-.pdf","og_locale":"en_US","og_type":"article","og_title":"211108 - PM - Dextech -Styrelsen i DexT ech fo\u0308resla\u030ar en fo\u0308retra\u0308desemission | DexTech","og_url":"https:\/\/dextechmedical.com\/wp-content\/uploads\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo?_resla?_r-en-fo?_retra?_desemission-.pdf","og_site_name":"DexTech","article_modified_time":"2021-11-08T12:54:05+00:00","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dextechmedical.com\/wp-content\/uploads\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo?_resla?_r-en-fo?_retra?_desemission-.pdf","url":"https:\/\/dextechmedical.com\/wp-content\/uploads\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo?_resla?_r-en-fo?_retra?_desemission-.pdf","name":"211108 - PM - Dextech -Styrelsen i DexT ech fo\u0308resla\u030ar en fo\u0308retra\u0308desemission | DexTech","isPartOf":{"@id":"https:\/\/dextechmedical.com\/#website"},"datePublished":"2021-11-08T12:32:58+00:00","dateModified":"2021-11-08T12:54:05+00:00","breadcrumb":{"@id":"https:\/\/dextechmedical.com\/wp-content\/uploads\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo?_resla?_r-en-fo?_retra?_desemission-.pdf#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dextechmedical.com\/wp-content\/uploads\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo?_resla?_r-en-fo?_retra?_desemission-.pdf"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dextechmedical.com\/wp-content\/uploads\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo?_resla?_r-en-fo?_retra?_desemission-.pdf#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dextechmedical.com\/en\/"},{"@type":"ListItem","position":2,"name":"The Board of Directors of DexTech proposes a rights issue of approx. MSEK 58.2 in order to further develop the project with multiple myeloma to clinical research and further verify OsteoDex&#8217;s value","item":"https:\/\/dextechmedical.com\/en\/the-board-of-directors-of-dextech-proposes-a-rights-issue-of-approx-msek-58-2-in-order-to-further-develop-the-project-with-multiple-myeloma-to-clinical-research-and-further-verify-osteodexs-value\/"},{"@type":"ListItem","position":3,"name":"211108 &#8211; PM &#8211; Dextech -Styrelsen i DexT ech fo\u0308resla\u030ar en fo\u0308retra\u0308desemission"}]},{"@type":"WebSite","@id":"https:\/\/dextechmedical.com\/#website","url":"https:\/\/dextechmedical.com\/","name":"DexTech","description":"Ett svenskt forskningsf\u00f6retag specialiserat p\u00e5 urologisk onkologi fr\u00e4mst prostatacancer","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dextechmedical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/dextechmedical.com\/wp-content\/uploads\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo\u0308resla\u030ar-en-fo\u0308retra\u0308desemission-.pdf'>211108 - PM - Dextech -Styrelsen i DexT ech fo\u0308resla\u030ar en fo\u0308retra\u0308desemission<\/a><\/p>\n"},"caption":{"rendered":"<p>211108 &#8211; PM &#8211; Dextech -Styrelsen i DexT ech fo\u0308resla\u030ar en fo\u0308retra\u0308desemission<\/p>\n"},"alt_text":"","media_type":"file","mime_type":"application\/pdf","media_details":{},"post":1399,"source_url":"https:\/\/dextechmedical.com\/wp-content\/uploads\/211108-PM-Dextech-Styrelsen-i-DexT-ech-fo\u0308resla\u030ar-en-fo\u0308retra\u0308desemission-.pdf","_links":{"self":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/media\/1394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/comments?post=1394"}],"wp:attached-to":[{"embeddable":true,"post_type":"post","id":1399,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/posts\/1399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}